文献速递血液净化与透析

整合式居家透析转衔方案的患者结局:加拿大器官替代登记研究

Outcomes of Integrated Home Dialysis Care: Results From the Canadian Organ Replacement Register.
PubMed 文献 · Am J Kidney Dis · 2023-08-30

该研究基于加拿大器官替代登记(CORR)2005–2018年数据,比较腹膜透析(PD)转居家血液透析(HHD)与直接起始HHD患者的结局。倾向评分匹配分析显示,在匹配透析龄后,PD转HHD组复合终点风险低于直接起始HHD组(HR 0.61, 95%CI 0.40–0.94),住院风险两组相似。

要点

  • 匹配透析龄后,PD转HHD组复合终点风险低于直接起始HHD组(HR 0.61, 95%CI 0.40–0.94)。
  • 两组住院风险在两种匹配分析中均无显著差异。
  • PD转HHD患者中位PD治疗时间为1.9年。

核心结论

  • 控制透析龄后,PD转HHD患者的临床结局优于直接起始HHD患者。

研究设计与样本

  • 基于加拿大器官替代登记(CORR)的观察性分析,纳入2005–2018年间起始透析90天内开始PD或HHD的全部患者。
  • 共纳入63,327例,其中PD转HHD组163例(中位PD治疗1.9年),直接起始HHD组711例。
  • 采用倾向评分1:1匹配,分别进行“起始匹配”(与起始HHD患者匹配)和“透析龄匹配”(与透析龄至少相当于PD转HHD组转衔时透析龄的HHD患者匹配)分析。
  • 复合终点采用病因特异性风险模型,住院(复发性事件)采用共享frailty模型。

主要发现

  • 起始匹配分析中,PD转HHD组与直接起始HHD组复合终点风险相似(HR 0.88, 95%CI 0.58–1.32)。
  • 起始匹配分析中,两组住院风险相似(HR 1.04, 95%CI 0.76–1.41)。
  • 透析龄匹配分析中,PD转HHD组复合终点风险低于直接起始HHD组(HR 0.61, 95%CI 0.40–0.94)。
  • 透析龄匹配分析中,两组住院风险相似(HR 0.85, 95%CI 0.59–1.24)。

临床怎么用

  • 研究数据支持对起始居家肾脏替代治疗的患者采用整合式居家透析模式(PD起始,适时转HHD)。

局限性

  • PD转HHD队列存在幸存者偏倚风险。
  • 存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: The integrated home dialysis model proposes the initiation of kidney replacement therapy (KRT) with peritoneal dialysis (PD) and a timely transition to home hemodialysis (HHD) after PD ends. We compared the outcomes of patients transitioning from PD to HHD with those initiating KRT with HHD. STUDY DESIGN: Observational analysis of the Canadian Organ Replacement Register (CORR). SETTINGS & PARTICIPANTS: All patients who initiated PD or HHD within the first 90 days of KRT between 2005 and 2018. EXPOSURE: Patients transitioning from PD to HHD (PD+HHD group) versus patients initiating KRT with HHD (HHD group). OUTCOME: (1) A composite of all-cause mortality and modality transfer (to in-center hemodialysis or PD for 90 days) and (2) all hospitalizations (considered as recurrent events). ANALYTICAL APPROACH: A propensity score analysis for which PD+HHD patients were matched 1:1 to (1) incident HHD patients ("incident-match" analysis) or (2) HHD patients with a KRT vintage at least equivalent to the vintage of PD+HHD patients at the transition time ("vintage-matched" analysis). Cause-specific hazards models (composite outcome) and shared frailty models (hospitalization) were used to compare groups. RESULTS: Among 63,327 individuals in the CORR, 163 PD+HHD patients (median of 1.9 years in PD) and 711 HHD patients were identified. In the incident-match analysis, compared to the HHD patients, the PD+HHD group had a similar risk of the composite outcome (HR, 0.88 [95% CI, 0.58-1.32]) and hospitalizations (HR, 1.04 [95% CI, 0.76-1.41]). In the vintage-match analysis, PD+HHD patients had a lower hazard for the composite outcome (HR, 0.61 [95% CI, 0.40-0.94]) but a similar hospitalization risk (HR, 0.85 [95% CI, 0.59-1.24]). LIMITATIONS: Risk of survivor bias in the PD+HHD cohort and residual confounding. CONCLUSIONS: Controlling for KRT vintage, the patients transitioning from PD to HHD had better clinical outcomes than the incident HHD patients. These data support the use of integrated home dialysis for patients initiating home-based KRT. PLAIN-LANGUAGE SUMMARY: The integrated home dialysis model proposes the initiation of dialysis with peritoneal dialysis (PD) and subsequent transition to home hemodialysis (HHD) once PD is no longer feasible. It allows patients to benefit from initial lifestyle advantages of PD and to continue home-based treatments after its termination. However, some patients may prefer to initiate dialysis with HHD from the outset. In this study, we compared the long-term clinical outcomes of both approaches using a large Canadian dialysis register. We found that both options led to a similar risk of hospitalization. In contrast, the PD-to-HHD model led to improved survival when controlling for the duration of kidney failure.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Desbiens LC, Tennankore KK, Goupil R, et al. Outcomes of Integrated Home Dialysis Care: Results From the Canadian Organ Replacement Register. Am J Kidney Dis. 2023. PMID: 37657633. doi:10.1053/j.ajkd.2023.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。